Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU4ATAC15P is a human pseudogene annotated as “RNA, U4atac small nuclear 15, pseudogene”. It is classified as a non-coding RNA pseudogene, meaning it resembles the functional U4atac snRNA gene (which is essential for the minor spliceosome complex and minor intron splicing) but lacks the capacity to produce a functional product. There is no evidence of transcriptional activity, protein coding, or association with biological functions, disease processes, or drug interactions. Unlike the functional RNU4ATAC gene, which is implicated in rare genetic syndromes through pathogenic variants[6], RNU4ATAC15P is not a therapeutic target, is not used clinically, and does not belong to a druggable molecular family. This entry is sometimes confused with the functional U4atac snRNA gene (*RNU4ATAC*), mutations in which are associated with developmental syndromes (Taybi-Linder/MOPD1, Roifman, Lowry-Wood)[6]. However, *RNU4ATAC15P* is strictly a pseudogene variant and lacks current biological or clinical relevance[1][5].
None (No therapeutic mechanism of action, as it is not a drug target[1][5].)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4atac small nuclear 15, pseudogene (RNU4ATAC15P).